Angina after PCI in coronary heart disease
Conditions
Interventions
intervention group:Peach tongluo granules are brewed
Sponsors
Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. The patient met the diagnostic criteria for coronary atherosclerotic heart disease (mainly referring to the 2018 "Guidelines for the Diagnosis and Treatment of Stable Coronary Heart Disease" of the Cardiovascular Disease Branch of the Chinese Medical Association, the 2015 "Guidelines for the Diagnosis and Treatment of Acute ST-Segment Elevation Myocardial Infarction" of the Cardiovascular Disease Branch of the Chinese Medical Association, and the "Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndrome" in 2016 Treatment Guidelines" ), patients with a clear history of coronary heart disease and PCI, patients with angina developing within 12 months after PCI surgery; 2. Those who meet the dialectical criteria of TCM qi pulse inconsistency in coronary heart disease (refer to the diagnostic criteria for "chest paralysis" in the 2002 edition of the Guidelines for Clinical Research of New Drugs in Chinese Medicines. Refer to the "Consensus of Traditional Chinese Medicine Diagnosis and Treatment of Coronary Heart Disease Stable Angina". Refer to Academician Zhang Boli's "Study on Macroscopic Diagnostic Criteria for Blood Stasis In Coronary Heart Disease", screen the relevant entries of the qi pulse failure, and finally confirm the relevant evidence items of the qi pulse failure). 3. Aged 18-75 years, gender agnostic; 4. Those who voluntarily sign written informed consent.
Exclusion criteria
Exclusion criteria: 1. Accompanied by serious primary diseases such as liver, kidney, hematopoietic system and acute cardiovascular and cerebrovascular diseases; 2. Other psychiatric positive family history and personal history; 3. Those with cognitive impairment and poor treatment adherence; 4. Those who cannot take the drug in accordance with the regulations; 5. Those who take other trial drugs or are participating in other clinical studies within 1 month before being selected for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| troponin;Brain natriuretic peptides;Seattle Angina Scale;C-reactive protein;Interleukin-6; | — |
Secondary
| Measure | Time frame |
|---|---|
| Tumor necrosis factor-alpha;SAS, Self-Rating Anxiety Scale;SDS, Self-rating Depression Scale; | — |
Countries
China
Contacts
Public ContactZhang Ying
Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed